| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 800 | ₹1.1 0% | 13,9500% |
| 00% | ₹126.7 0% | 820 | ₹1.95 0% | 67,4250% |
| - | - | 840 | ₹2.15 -54.73% | 17,825-42.5% |
| - | - | 850 | ₹2.65 1.92% | 20,9250% |
| - | - | 860 | ₹3.2 3.22% | 26,3506.25% |
| - | - | 870 | ₹4.4 -17.75% | 6,97512.5% |
| 7750% | ₹76.15 0% | 880 | ₹5.35 4.9% | 60,4501.29% |
| 4,650100% | ₹71.85 0.27% | 890 | ₹6.25 -4.58% | 7,75011.11% |
| 20,1500% | ₹67.55 0% | 900 | ₹8.4 7.69% | 1,98,400-1.91% |
| 4,6500% | ₹49.35 0% | 920 | ₹13.15 10.5% | 34,1004.76% |
| 51,1500% | ₹41.65 16.34% | 930 | ₹16.25 2.84% | 37,20026.31% |
| 19,3750% | ₹38.35 0% | 940 | ₹20 8.1% | 80,6001.96% |
| 1,93,75027.55% | ₹30 -0.66% | 950 | ₹24.4 2.95% | 1,05,40014.28% |
| 1,03,8506.34% | ₹24.7 -3.89% | 960 | ₹29.7 9.79% | 58,12510.29% |
| 3,8750% | ₹24.15 10.52% | 970 | ₹37 0% | 7,7500% |
| 36,4259.30% | ₹16.8 -1.17% | 980 | ₹47.35 0% | 20,9250% |
| 19,37531.57% | ₹13.6 -6.52% | 990 | ₹49.85 0% | 7750% |
| 2,62,7253.35% | ₹11.15 -2.19% | 1,000 | ₹51.25 0% | 23,2500% |
| 7750% | ₹8.4 0% | 1,010 | ₹64.45 0% | 1,5500% |
| 86,0251.83% | ₹7 -7.89% | 1,020 | - | - |
| 3,8750% | ₹23.15 0% | 1,030 | - | - |
| 33,32519.44% | ₹4.8 5.49% | 1,040 | - | - |
| 15,5005.26% | ₹3.5 1.44% | 1,050 | - | - |
| 7,750400% | ₹2.75 -82.25% | 1,060 | - | - |
| 41,0751225% | ₹1.8 -40.98% | 1,080 | - | - |
| 3,100300% | ₹1.4 -80% | 1,100 | - | - |
| 19,375150% | ₹1 -16.66% | 1,120 | ₹164 0% | 3,1000% |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
